USNA - USANA HEALTH SCIENCES INC


27.89
0.350   1.255%

Share volume: 220,213
Last Updated: 04-29-2025
Pharmaceutical Products/Medicinal Chemicals: -0.08%

PREVIOUS CLOSE
CHG
CHG%

$27.54
0.35
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
83%
Profitability 89%
Dept financing 50%
Liquidity 75%
Performance 87%
Company vs Stock growth
vs
Performance
5 Days
2.61%
1 Month
3.41%
3 Months
-19.99%
6 Months
-24.09%
1 Year
-32.83%
2 Year
-58.34%
Key data
Stock price
$27.89
P/E Ratio 
13.29
DAY RANGE
$27.39 - $28.15
EPS 
$4.54
52 WEEK RANGE
$23.10 - $49.78
52 WEEK CHANGE
-$38.77
MARKET CAP 
722.462 M
YIELD 
N/A
SHARES OUTSTANDING 
19.052 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-22-2025
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$255,088
AVERAGE 30 VOLUME 
$222,754
Company detail
CEO: Kevin G. Guest
Region: US
Website: usana.com
Employees: 1,900
IPO year: 1995
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA nutritional products comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups. Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.

Recent news

USANA Celavive Postbiotic Rescue Serum Selected as a Good Housekeeping 2025 Beauty Award Winner

USANA Health Sciences, Inc., a global leader in cellular nutrition, announced today that its Celavive Postbiotic Rescue Serum was named as a winner in Good Housekeeping's 2025 Beauty Awards. The full list of awards can be found here.

Read more

USANA Health Sciences First Quarter 2025 Earnings: Beats Expectations

USANA Health Sciences ( NYSE:USNA ) First Quarter 2025 Results Key Financial Results Revenue: US$249.5m (up 9.5% from...

Read more

Usana Health Sciences Inc (USNA) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...

Usana Health Sciences Inc (USNA) reports a 12% increase in net sales, driven by growth in China and successful product launches, despite challenges in consumer sentiment and trade policies.

Read more